WeightlessRx is an U.S. telehealth provider of medically supervised GLP-1 weight loss treatment.
“Compounded semaglutide has the same active ingredient (semaglutide) as the molecule in Ozempic and Wegovy. It is made by licensed U.S. compounding pharmacies selected by your clinician. Compounded medications are not reviewed by the FDA for safety, quality, or efficacy.”
“WeightlessRx offers physician-supervised compounded GLP-1 weight-loss treatment with two medication options: compounded semaglutide (a GLP-1 receptor agonist, once-weekly injection) and compounded tirzepatide (a dual GLP-1 / GIP receptor agonist, once-weekly injection). Both come with personalized dosing, unlimited clinician messaging, a GLP-1 fitness app, on-demand workouts, meal plans, and 1-on-1 nutrition coaching.”
“You take a 90-second medical intake, meet with a U.S.-licensed clinician via telehealth, and — if clinically appropriate — your prescription ships free in discreet packaging from a licensed U.S. compounding pharmacy. You get unlimited messaging with your clinician, titration guidance, proactive side-effect support, and access to the WeightlessRx app (workouts, meal plans, nutrition coach).”
“WeightlessRx is available in all 50 U.S. states. Prescriptions are written by U.S.-licensed clinicians in your state of residence and shipped nationwide from our partner compounding pharmacy.”
Download this profile and inspect its supporting evidence.